HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy.

Abstract
Chemotherapy is the basis of treatment of paracoccidioidomycosis in its various forms. Depending on the Paracoccidioides brasiliensis virulence, the status of host immunity, the degree of tissue involvement and fungal dissemination, treatment can be extended for long periods with an alarming frequency of relapses. Association of chemotherapy with a vaccine to boost the cellular immune response seemed a relevant project not only to reduce the time of treatment but also to prevent relapses and improve the prognosis of anergic cases. The candidate immunogen is the gp43 major diagnostic antigen of P. brasiliensis and more specifically its derived peptide P10, carrying the CD4+ T-cell epitope. Both gp43 and P10 protected Balb/c mice against intratracheal infections with virulent P. brasiliensis strain. P10 as single peptide or in a multiple-antigen-peptide (MAP) tetravalent construction was protective without adjuvant either by preimmunization and intratracheal challenge or as a therapeutic agent in mice with installed infection. P10 showed additive protective effects in drug-treated mice stimulating a Th-1 type immune response with high IFN-gamma and IL-12. P10 and few other peptides in the gp43 were selected by Tepitope algorithm and actually shown to promiscuously bind several prominent HLA-DR molecules suggesting that a peptide vaccine could be devised for a genetically heterogenous population. P10 was protective in animals turned anergic, was effective in a DNA minigene vaccine, and increased the protection by monoclonal antibodies in Balb/c mice. DNA vaccines and peptide vaccines are promising therapeutic tools to be explored in the control of systemic mycoses.
AuthorsLuiz R Travassos, Elaine G Rodrigues, Leo K Iwai, Carlos P Taborda
JournalMycopathologia (Mycopathologia) 2008 Apr-May Vol. 165 Issue 4-5 Pg. 341-52 ISSN: 0301-486X [Print] Netherlands
PMID18777638 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • 43 kDa protein, Paracoccidioides
  • Adjuvants, Immunologic
  • Antifungal Agents
  • Antigens, Fungal
  • Fungal Proteins
  • Fungal Vaccines
  • Glycoproteins
  • Peptides
Topics
  • Adjuvants, Immunologic (therapeutic use)
  • Amino Acid Sequence
  • Animals
  • Antifungal Agents (therapeutic use)
  • Antigens, Fungal (chemistry, immunology)
  • Combined Modality Therapy
  • Fungal Proteins (chemistry, immunology)
  • Fungal Vaccines (administration & dosage, chemical synthesis, chemistry, immunology)
  • Glycoproteins (chemistry, immunology)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • Paracoccidioides (immunology)
  • Paracoccidioidomycosis (microbiology, prevention & control)
  • Peptides (administration & dosage, chemical synthesis, chemistry, immunology)
  • Treatment Outcome
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: